HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat

Biochem Biophys Res Commun. 1995 Jun 6;211(1):130-6. doi: 10.1006/bbrc.1995.1787.

Abstract

In the present experiments we have used morphological techniques to study the neuropathological profile of the brain of rats after intracerebroventricular (i.c.v.) injection of recombinant HIV-1 gp 120. Using brain cryostat sections (10 microns) from rats treated with a single, daily dose of gp120 (100 ng/rat) given for 7 and 14 consecutive days, in situ DNA fragmentation was revealed in the neocortex but not in the hippocampus by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end-labelling (TUNEL). In these rats, dark degenerating neurones were observed in the neocortex but not in the hippocampus. Treatment with bovine serum albumin (300 ng/rat, i.c.v.) for up to 14 days did not produce DNA fragmentation nor did it yield neuropathological lesions of the neocortex or hippocampus. In conclusion, the present data demonstrate that gp 120 given i.c.v. produced DNA fragmentation in the neocortex, thus suggesting that apoptosis is the mechanism through which neurones of the neocortex are killed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / metabolism*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism*
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / physiology*
  • DNA / drug effects
  • DNA Damage*
  • HIV Envelope Protein gp120 / administration & dosage
  • HIV Envelope Protein gp120 / pharmacology*
  • HIV-1*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Injections, Intraventricular
  • Male
  • Neurons / drug effects
  • Neurons / metabolism
  • Organ Specificity
  • Rats
  • Rats, Wistar
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology

Substances

  • HIV Envelope Protein gp120
  • Recombinant Proteins
  • DNA